GlobeNewsWire
09 Oct 2025, 15:01 UTC · 49w ago
Verdict
Headline takes no side. We score EDIT +0.90 across one claim — strongly bullish.
+0.90strongly bullish
More positive than 94% of ticker scores this week
What the story claims
1 claim · scored −1 bearish … +1 bullish
Preclinical data for EDIT-401 shows a mean LDL-C reduction of 90% or more in non-human primates and mouse models.
More positive than 92% of claims this week
Which stocks this story touches
Continue reading
5 related stories
Scored by the NIS engine · methodology.
More positive than 94% of ticker scores this week
Positive preclinical data showing significant LDL-C reduction for the company's EDIT-401 candidate.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
−31.6%
Price is moving against the score
$2.84 vs $4.15 close before publication (Oct 8) · not market-adjusted
EDIT chart →
